SCHEMBL19862207

SCHEMBL19862207

C1=Cc2ccc(-c3cc(-c4ccc(-c5cccnc5)nc4)nc(-c4ccccc4)n3)cc2C2(c3ccccc31)c1ccccc1-c1c2ccc2c1sc1ccccc12

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.33
DHODH Q02127 1/20 0.30
CYP19A1 P11511 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862159 0.98 PDK2 (0.32) PDK2DHODH
SCHEMBL19862188 0.97 PDK2 (0.33) PDK2DHODHCYP19A1
SCHEMBL19862120 0.93 DHODH (0.35) PDK2DHODHCYP19A1
SCHEMBL19862155 0.93 DHODH (0.35) PDK2DHODHCYP19A1
SCHEMBL19862134 0.93 PDK2 (0.35) PDK2DHODHCYP19A1
SCHEMBL20224327 0.91 PDK2 (0.34) PDK2DHODHCYP19A1
SCHEMBL19862209 0.91 DHODH (0.35) PDK2DHODHCYP19A1
SCHEMBL19862205 0.91 GBA1 (0.34) PDK2
SCHEMBL19862110 0.90 PDK2 (0.35) PDK2DHODHCYP19A1
SCHEMBL19862121 0.90 ALOX5 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ORC3, AOX1, RCOR3 PDK2 2964/4885DHODH 1612/4885CYP19A1 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.